The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Energy Security In The Asian Century
Asia's energy use would lead to a doubling of carbon dioxide emissions unless it fundamentally changes the way it consumes energy, says a new ADB report.
BRICS Countries Agree To US$50 Billion Development Bank
The five BRICS countries have agreed to set up a bank that will fund development and infrastructure projects in developing countries.
Agrochemicals Linked To Chronic Kidney Disease In Sri Lanka
Researchers have linked the high prevalence of chronic kidney disease in Sri Lanka to indiscriminate use of fertilizers and pesticides.
Singapore Ranked Second In IT Readiness By World Economic Forum
The Nordic countries and the Asian Tigers dominate a 2013 World Economic Forum ranking of IT-ready economies.
Have You Ever Been Stared At? It Could All Be In Your Head.
People often think that other people are staring at them even when they aren't, according to new research from the University of Sydney.
Sanofi Aventis & Multicare Ink Strategic Agreement In The Philippines
Sanofi-Aventis Philippines Inc. and Multicare Pharmaceuticals have entered into a marketing and distribution agreement.
Taiwanese Scientists Develop A Saliva Test For DNA Damage & Cancer Risk
Scientists in Taiwan have developed a new test to measure the amount of carcinogens attached to our DNA just by testing our spit.
Dr. Reddy’s Initiates Phase II Study With CETP Inhibitor, DRL-17822
Dr. Reddy’s Laboratories announced this week the initiation of a Phase II study of DRL-17822 in patients with diagnosis of type II dyslipidemia.
Hatchtech Completes Treatment Phase Of DeOvo Phase IIb Trial For Head Lice
Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase IIb clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.